Rhinoscleroma

RaafiulZargar 2,282 views 26 slides Jun 15, 2019
Slide 1
Slide 1 of 26
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26

About This Presentation

Google drive:-https://drive.google.com/open?id=1hd2LAIPo3iA5Z5G9RxCSxUT5LPtrohQO
Youtube:-https://www.youtube.com/watch?v=b1pIsGq1XhI


Slide Content

R HIN O SCLE R OM A R AA F I U L B ASH E E R

INTRODUCTION INCIDENCE ETIOPATHOGENESIS CLINICAL FEATURES DIAGNOSIS TREATMENT TABLE OF CONTENTS OVERVIEW

INTRODUCTION COINED BY:- VON HEBRA IN 1870 DEFINITION Respiratory scleroma or rhinoscleroma is a progressive granulomatous disease commencing in the nose and later extending into the nasopharynx and oropharynx, the larynx and sometimes the trachea and bronchi. Respiratory scleroma or rhinoscleroma is a progressive granulomatous disease commencing in the nose and later extending into the nasopharynx and oropharynx, the larynx and sometimes the trachea and bronchi.

INCIDENCE

INCIDENCE (INDIA)

ETIOPATHOGENESIS ETIOLOGY Klebsiella rhinoscleromatis Frisch bacillus Gram negative Intracellular

RISK FACTORS MULTIFACTORIAL LOW SOCIO ECONOMIC STATUS POOR DOMESTIC HYGIENE OVERCROWDING 1 2 3 4

ROUTE OF ENTRY DROPLET NUCLEI

ROUTE OF ENTRY DROPLET NUCLEI ENTRY INTO MUCOSA OF OROPHARYNX & LARYNGOPHARYNX

ROUTE OF ENTRY DROPLET NUCLEI ENTRY INTO MUCOSA OF OROPHARYNX & LARYNGOPHARYNX INTRACELLULAR SURVIVAL ENGULFED BY MACROPHAGES MUCKLICZ CELLS MUCOPOLYSACCHARIDES SUPPORT INTRACELLULAR SURVIVAL

C LINI C A L F E AT U RE S SUBDERMAL INFILTRATION PROGRESSES THROUGH 4 STAGES - CATARRHAL STAGE ATROPIC STAGE GRANULOMATOUS STAGE CICATRICIAL STAGE STAGE-I CATARRHAL STAGE FOUL SMELLING DISCHARGE (CARPENTER’S GLUE) DURATION-WEEKS TO MONTHS STAGE-II ATROPIC STAGE FEATURES OF ATROPHIC RHINITIS CRUST FORMATION CRUST STAGE-III GRANULOMATOUS/PROLIFERATIVE/NODULAR STAGE NODULES PAINLESS & NON-ULCERATIVE INITIALLY- BLUISH-RED & RUBBERY LATER- PALE & INDURATED TAPIR’S NOSE SHAPE AND CONTOUR OF NOSE CHANGES WOODY FEEL ` STAGE-IV CICATRICIAL STAGE ADHESIONS & STENOSIS MIGHT OCCUR TO DISTORT NORMAL ANATOMY MC SITE AFFECTED IN NOSE ANT. PART OF NASAL SEPTUM COMMONEST PRESENTATION NASAL OBSTRUCTION MC SITE AFFECTED IN LARYNX SUBGLOTTIS GOTHIC SIGN DUE TO FIBROSIS PHARYNGEAL WALL IS PULLED UP & IT RESEMBLES TOP OF A CHURCH

KEY POINTS STAGES CLINICAL FEATURES CATARRHAL CARPENTERS GLUE ATROPHIC CRUST FORMATION NODULAR HEBRA NOSE CICATRICIAL STENOSIS+FIBROSIS

INVESTIGATIONS SUBMUCOSA INFILTRATED WITH PLASMA CELLS , LYMPHOCYTES , EOSINOPHILS , MIKULICZ CELLS AND RUSSEL BODIES MIKCULICZ CELLS (DIAGNOSTIC) FOAM CELLS CONTAIN CAUSATIVE ORGANISM RUSSEL BODIES (DIAGNOSTIC) FOUND IN PLASMA CELLS ACCUMULATION OF Ig’s BIOPSY

D I A G N O S I S BASED ON REACTION OF PATIENT’S SERUM WITH SUSPENSION OF Klebsiella rhinoscleromatis . HIGH TITRES OF ANTIBODIES AGAINST K. rhinoscleromatis INDICATES INTACT HUMORAL IMMUNITY. COMPLEMENT FIXATION TEST ( LEVIN TEST )

D I A G N O S I S INTRACRANIAL EXTENSION OF RHINOSCLEROMA INTO ANTERIOR CRANIAL CAVITY VIA DESTRUCTION OF POSTERIOR BONY WALL OF LEFT SPHENOIDAL SINUS CT SCAN

D I A G N O S I S T1-WEIGHTED NASAL MASS EXTENDING INTO NASOPHARYNX MRI

D I A G N O S I S MUCOID DOME SHAPED STICKY PINK COLOURED LACTOSE FERMENTING COLONIES CULTURE ( MacConkey AGAR )

D I A G N O S I S PAS GIEMSA WARTHIN STARRY SILVER STAINS PAS STAIN INCLUSION BODIES CONTAIN CAUSATIVE ORGANISM

COMPLICATIONS EXTERNAL NOSE DEFORMITY VESTIBULAR STENOSIS CICATRIZATION OF SOFT PALATE NASAL REGURGITATION TRACHEAL STENOSIS

DISEASE FOLLOWS A PROTRACTED BUT USUALLY SELF LIMITING COURSE ENDING IN CICATRIZING STAGE ORGANISM CAN BE EXTREMELY DIFFICULT TO ERRADICATE BY ANTIMICROBIALS ONCE DIAGNOSIS IS CONFIRMED THE TREATMENT SHOULD BE INTENSE AND PROLONGED LINES OF TREATMENT ANTIBIOTICS STEROIDS RADIOTHERAPY SURGERY TREATMENT MEDICAL

DRUGS STREPTOMYCIN I.M 1GM FOR 4-6 WEEKS TETRACYCLINE 500MG Q.I.D RIFAMPICIN 400MG FOR 6 WEEKS ORALLY NASAL INSTILLATION NASAL INFILTRATIOMN COTRIMOXAZOLE+CIPROFLOXACIN ACRIFLAVIN 2% LOCALLY 8 WEEKS BACTERICIDAL ANTIBIOTICS LARGE DOSES GIVEN FOR MIN. DURATION OF 4-6 WEEKS CONTINUED TILL 2 CONSECUTIVE CULTURES FROM BIOPSY MATERIAL ARE PROVEN NEGATIVE

CONTENT CARBOLIC ACID(0.2ML) GLACIAL ACETIC ACID(0.2ML) GLYCERIN(0.4ML) D/W(10ML) ROUTE INJECTED LOCALLY MECHANISM CHEMICAL NECROSIS OF GRANULOMA 8-10 INJ. LEADS TO COMPLETE REGRESSION OF GRANULOMA AND RESTORATION OF NORMAL NASAL PATENCY Kalisa regimen

DOSE 3000-3500 GY DURATION 3 WEEKS MECHANISM DESTROYS SCLEROMA BY RADIATION CURRENTLY NOT REQUIRED IRRADIATION

COMBINED WITH ANTIBIOTICS TO REDUCE FIBROSIS INTRALESIONAL STEROIDS

REQUIRED IN 4 TH STAGE OF FIBROSIS AND STENOSIS PLASTIC RECONSTRUCTIVE SURGERY CARRIED OUT BY LASER AND NASAL ENDOSCOPY SILASTIC STENT FACILITATES RE-EPITHELISATION USES ESTABLISHES AIRWAY CORRECT THE NASAL DEFORMITY SURGERY

THANK YOU